We are live on ! Find out more
BHVN

Biohaven Pharmaceutical Holding Company Ltd.
BHVN

Delisted

BHVN was delisted on the 3rd of October, 2022.

Back to rankings

69 hedge funds and large institutions have $335M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2017 Q2 according to their latest regulatory filings, with 69 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
+69
Holders Change %
–
% of All Funds
1.72%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.1%
New
69
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$56.4M
2
VMI
VHCP Management II
New York
+$38.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.8M
4
BlackRock
BlackRock
New York
+$23.5M
5
KCM
Knoll Capital Management
Florida
+$18.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$61.2M +$56.4M +2,448,350 New
VMI
2
VHCP Management II
New York
$37.9M +$38.3M +1,664,300 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$25.9M +$23.8M +1,035,523 New
BlackRock
4
BlackRock
New York
$25.5M +$23.5M +1,020,932 New
KCM
5
Knoll Capital Management
Florida
$20.2M +$18.6M +807,224 New
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$16.1M +$14.9M +645,743 New
JP Morgan Chase
7
JP Morgan Chase
New York
$14.8M +$13.7M +593,225 New
EA
8
Emerald Advisers
Pennsylvania
$12.4M +$11.5M +497,880 New
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$12.4M +$11.4M +496,128 New
AllianceBernstein
10
AllianceBernstein
Tennessee
$10.9M +$10M +435,209 New
Stifel Financial
11
Stifel Financial
Missouri
$10.4M +$9.56M +415,200 New
Wellington Management Group
12
Wellington Management Group
Massachusetts
$8.9M +$8.2M +356,107 New
EMFAT
13
Emerald Mutual Fund Advisers Trust
Pennsylvania
$8.81M +$8.12M +352,560 New
RSCM
14
Rock Springs Capital Management
Maryland
$7.67M +$7.07M +307,000 New
YU
15
Yale University
Connecticut
$6.25M +$5.76M +250,000 New
DM
16
Deerfield Management
New York
$5.42M +$4.99M +216,761 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$4.12M +$3.8M +164,904 New
Alyeska Investment Group
18
Alyeska Investment Group
Illinois
$3.74M +$3.45M +149,651 New
Vanguard Group
19
Vanguard Group
Pennsylvania
$3.2M +$2.95M +128,102 New
HIM
20
Hillhouse Investment Management
Cayman Islands
$3M +$2.76M +120,000 New
PA
21
Perceptive Advisors
New York
$3M +$2.76M +120,000 New
State Street
22
State Street
Massachusetts
$2.93M +$2.7M +117,212 New
Northern Trust
23
Northern Trust
Illinois
$2.83M +$2.6M +113,027 New
Bank of America
24
Bank of America
North Carolina
$2.46M +$2.26M +98,318 New
NIP
25
Nicholas Investment Partners
California
$2.41M +$2.22M +96,218 New
1
2 3

BHVN Hedge Fund Activity: Q2 2017 in Review

69 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Biohaven Pharmaceutical Holding Company Ltd. (BHVN) for Q2 2017, worth a combined $335M.

Buyers outnumbered sellers: 69 funds opened new BHVN positions and 0 closed out — a net gain of 69 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $56.4M.

  • 69 institutional investors held Biohaven Pharmaceutical Holding Company Ltd. (BHVN) as of Q2 2017, up from 0 in Q1 2017.
  • Funds reported $335M of Biohaven Pharmaceutical Holding Company Ltd. stock for Q2 2017.
  • 69 funds opened new Biohaven Pharmaceutical Holding Company Ltd. positions in Q2 2017 and 0 closed out, a net change of +69 holders.
  • The largest Biohaven Pharmaceutical Holding Company Ltd. buyer in Q2 2017 was RA Capital Management, an estimated $56.4M added.

Based on aggregated 13F filings for Q2 2017.